PURPOSE OF REVIEW: The purpose is to review the development and current application of extracorporeal life support [ECLS, extracorporeal membrane oxygenation (ECMO)] in acute severe respiratory failure. RECENT FINDINGS: Extracorporeal support (ECMO) is used for acute severe respiratory failure in advanced ICUs. The current survival rate is 60-70%. Three controlled trials all demonstrated 20-30% improvement in survival compared to conventional care. Patients may now be maintained awake and ambulatory with spontaneous breathing. SUMMARY: ECMO is the next step in the algorithm for management of severe respiratory failure unresponsive to conventional care.
PURPOSE OF REVIEW: The purpose is to review the development and current application of extracorporeal life support [ECLS, extracorporeal membrane oxygenation (ECMO)] in acute severe respiratory failure. RECENT FINDINGS: Extracorporeal support (ECMO) is used for acute severe respiratory failure in advanced ICUs. The current survival rate is 60-70%. Three controlled trials all demonstrated 20-30% improvement in survival compared to conventional care. Patients may now be maintained awake and ambulatory with spontaneous breathing. SUMMARY: ECMO is the next step in the algorithm for management of severe respiratory failure unresponsive to conventional care.
Authors: Benjamin D Carr; Clinton J Poling; Pavel Hala; Matias Caceres Quinones; Aaron R Prater; Jennifer S McLeod; Robert H Bartlett; Alvaro Rojas-Pena; Ronald B Hirschl Journal: ASAIO J Date: 2020-05 Impact factor: 3.826
Authors: Benjamin D Carr; Thomas J Johnson; Amalia Gomez-Rexrode; Azmath Mohammed; Megan Coughlin; John M Toomasian; Alvaro Rojas-Pena; Robert H Bartlett; Jonathan W Haft Journal: ASAIO J Date: 2020-01 Impact factor: 3.826
Authors: N B Steuer; K Hugenroth; T Beck; J Spillner; R Kopp; S Reinartz; T Schmitz-Rode; U Steinseifer; G Wagner; J Arens Journal: Cardiovasc Eng Technol Date: 2020-05-13 Impact factor: 2.495